Ovarian Cancer Surgery

Ovarian Cancer Surgery is a highly specialized oncologic discipline focused on the operative management of primary and recurrent malignancies arising from the ovary, fallopian tube, and peritoneal surfaces. Presented at a global Surgical Science Conference, this session explores cytoreductive techniques, staging precision, and survival-enhancing strategies in ovarian tumor surgery. Given that ovarian cancer is often diagnosed at advanced stages due to subtle early symptoms, surgical intervention remains the cornerstone of disease control and long-term outcome improvement.

The primary objective of ovarian cancer surgery is complete cytoreduction, meaning maximal removal of visible tumor burden. Extensive procedures may include total hysterectomy, bilateral salpingo-oophorectomy, omentectomy, lymph node assessment, and peritoneal stripping. Achieving no gross residual disease significantly improves response to adjuvant chemotherapy and overall survival. Preoperative imaging and multidisciplinary planning are essential to evaluate disease distribution and determine resectability.

In early-stage disease, comprehensive surgical staging allows accurate classification and guides postoperative therapy decisions. Minimally invasive approaches may be considered in carefully selected patients, ensuring oncologic principles are maintained. Fertility-preserving surgery is possible in select early-stage cases, requiring precise tumor assessment and patient counseling.

Advanced or recurrent ovarian cancer often necessitates complex multivisceral resections involving bowel, diaphragm, or splenic surfaces. These procedures demand expertise in peritoneal surgery and coordinated perioperative management. Hyperthermic intraperitoneal chemotherapy (HIPEC) is increasingly integrated in selected cases to enhance locoregional control.

Postoperative care involves close monitoring for complications such as bleeding, infection, or thromboembolism. Long-term surveillance includes tumor marker evaluation and imaging follow-up. Collaboration between surgical oncologists, medical oncologists, and specialized nursing teams ensures comprehensive treatment continuity.

Emerging advancements in molecular profiling, targeted therapy integration, and personalized surgical planning are refining ovarian cancer management. By combining aggressive yet precise operative strategies with multidisciplinary oncology collaboration, ovarian cancer surgery continues to advance survival outcomes and quality of life for patients facing complex gynecologic malignancies.